Clinical Trial Update: Lemborexant for Sleep and Delirium Prevention in Elderly ICU Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial to evaluate lemborexant for sleep disturbances and delirium prevention in elderly ICU patients is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium
• Sleep Disorders

Drugs mentioned

• Dayvigo (lemborexant)

Snippet

Sponsor: Mahidol University | Conditions: Sleep Disturbance, Delirium | Phase 4 | Status: NOT_YET_RECRUITING